Skip to content

effect of Rasaushadhi and siravedhaprocedure in Headache.

A RANDOMIZED CLINICAL TRIAL ON THE EFFICACY OF SIRAVEDHA AND KUMKUMADI GHRITA NASYA ALONG WITH CHANDRAKANTA RASA ORALLY IN ARDHAVABHEDAKA W. S. R. TO MIGRAINE

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026557
Enrollment
30
Registered
2020-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

Intervention1: Nasya with Kumkumadi Ghrita: 15 patients of Ardhavbhedaka, Migraine will be administered with Kumkumadi Ghrita Nasya at dose of 8-10drops through nasal route for 7 days and repeat again

Sponsors

National Institute of Ayurveda Amer road Jorawar singh gate Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to participate in this trial through written informed consent. 2. Patients between18 to 55 years of age from either sex. 3. Patients presenting with symptoms of Ardhavabhedaka/ Migraine described as per Ayurveda and modern science.

Exclusion criteria

Exclusion criteria: 1. Secondary headaches caused by meningitis, tumors, encephalitis, head and neck trauma, trigeminal neuralgia, cervical spondylitis, refractive errors, sinusitis and other disorders of cranium, neck, eyes, ears, nose, sinuses, teeth etc. 2. Patients with complicated Migraine like status migrainosus, hemiplegic migraine and having any chronic debilitating disease with other neurological pathology. 3. Pregnant and lactating women. 4. Patients suffering from any other major systemic disorders e.g. tuberculosis, cancer, heart disease etc. 5. Patients unfit for Siravedha such as patients with hemorrhagic diseases (e.g. hemophilia), anaemia, hypotension, severe allergic diathesis and on anticoagulant treatment.

Design outcomes

Primary

MeasureTime frame
Changes in clinical manifestation of Ardhawbhedak w.s.r.to migraineTimepoint: 21 days

Secondary

MeasureTime frame
Changes in parameters of ardhawbhedak w.s.r.to MigraineTimepoint: 60 days.

Countries

India

Contacts

Public ContactDr Ajay kumar nayak

National institute of ayurveda,jaipur

shamsa_fiaz@yahoo.com8764009846

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026